📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Habit Modification of the Active Pharmaceutical Ingredient Lovastatin Through a Predictive Solvent Selection Approach. (2019)

First Author: Turner TD

Attributed to: Future Continuous Manufacturing and Advanced Crystallisation Research Hub funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.xphs.2018.12.012

PubMed Identifier: 30590015

Publication URI: http://europepmc.org/abstract/MED/30590015

Type: Journal Article/Review

Volume: 108

Parent Publication: Journal of pharmaceutical sciences

Issue: 5

ISSN: 0022-3549